PCN70 Healthcare Resource Utilization and Costs Among Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Anaplastic Lymphoma Kinase (ALK) Inhibitors
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.162
https://www.valueinhealthjournal.com/article/S1098-3015(21)00379-X/fulltext
Title :
PCN70 Healthcare Resource Utilization and Costs Among Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Anaplastic Lymphoma Kinase (ALK) Inhibitors
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00379-X&doi=10.1016/j.jval.2021.04.162
First page :
Section Title :
Open access? :
No
Section Order :
10742